122 - Trends in Auditory Regenerative Medicine: Spiral Therapeutics Novel Drug Delivery System

from This Week in Hearing · host This Week in Hearing

Meneire's disease is one of the toughest conditions for otolaryngologists to successfully treat. In this episode, Hugo Peris, CEO of Spiral Therapeutics and their Chief Medical Officer, Dr. Charles Limb, shed light on their company's clinical trials involving a new drug delivery system for treatment of Meniere's disease.    Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:   https://www.linkedin.com/company/this-week-in-hearing/  https://twitter.com/WeekinHearing

Episode metadata supplied by the publisher feed · Published Mar 6, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

122 - Trends in Auditory Regenerative Medicine: Spiral Therapeutics Novel Drug Delivery System

0:00 18:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Hearing?

This episode is 18 minutes long.

When was this This Week in Hearing episode published?

This episode was published on March 6, 2023.

Can I download this This Week in Hearing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!